OlavAndersen
PhD
Location
Berlin, Germany
Current Organization
Max Delbrück Center for Molecular Medicine
Grants
BrightFocus Foundation
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Alzheimer's Disease Research
Role of sorLA in Trafficking and Processing of APP
Active Dates
April 01, 2005 - March 31, 2007
Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine
Role of sorLA in Trafficking and Processing of APP
Active Dates
April 01, 2005 - March 31, 2007
Principal Investigator
Olav Andersen, PhD
Current Organization
Max Delbrück Center for Molecular Medicine